Presenting author

Michael Detke

1 presentation

• W1. The phase 2/3 gain trial of the first-generation p. gingivalis gingipain inhibitor atuzaginstat in mild-to-moderate probable Alzheimer’s disease: New cerebrospinal fluid biomarker data

  2026 ASCP Annual Meeting